Primary non-response and loss-of-response to first-line biological therapies are more common in patients with Ulcerative Colitis than Crohn's Disease - preliminary results from the Danish IBD Biobank Project

M. Zhao; L. Larsen; A. Dige; C. L. Hvas; A. Poulsen; D. Christiansen; M. Attauabi; B. Lo; M. Wewer; P. D. Ovesen; A. M. Petersen; F. Bendtsen; J. B. Seidelin; J. Burisch

doi:10.1093/ecco-jcc/jjab232.532

Primary non-response and loss-of-response to first-line biological therapies are more common in patients with Ulcerative Colitis than Crohn's Disease - preliminary results from the Danish IBD Biobank Project

M. Zhao, L. Larsen, A. Dige, C. L. Hvas, A. Poulsen, D. Christiansen, M. Attauabi, B. Lo, M. Wewer, P. D. Ovesen, A. M. Petersen, F. Bendtsen, J. B. Seidelin, J. Burisch

Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › peer review

Originalsprog	Engelsk
Tidsskrift	Journal of Crohn's & colitis
Vol/bind	16
Udgave nummer	Suppl. 1
Sider (fra-til)	I397-I398
ISSN	1873-9946
DOI	https://doi.org/10.1093/ecco-jcc/jjab232.532
Status	Udgivet - jan. 2022
Begivenhed	17th Congress of ECCO - Virtual Varighed: 16 feb. 2022 → 19 feb. 2022 Konferencens nummer: 17

Konference

Konference	17th Congress of ECCO
Nummer	17
Lokation	Virtual
Periode	16/02/2022 → 19/02/2022

Bibliografisk note

Abstrakt No. P405

Adgang til dokumentet

10.1093/ecco-jcc/jjab232.532

AUB Link

Søg efter materialet i Aalborg Universitetsbiblioteks søgemaskine

Citationsformater

Zhao, M., Larsen, L., Dige, A., Hvas, C. L., Poulsen, A., Christiansen, D., Attauabi, M., Lo, B., Wewer, M., Ovesen, P. D., Petersen, A. M., Bendtsen, F., Seidelin, J. B., & Burisch, J. (2022). Primary non-response and loss-of-response to first-line biological therapies are more common in patients with Ulcerative Colitis than Crohn's Disease - preliminary results from the Danish IBD Biobank Project. Journal of Crohn's & colitis, 16(Suppl. 1), I397-I398. https://doi.org/10.1093/ecco-jcc/jjab232.532

@article{1e1c21dfe73f4b0e9a75db687c9dc169,

title = "Primary non-response and loss-of-response to first-line biological therapies are more common in patients with Ulcerative Colitis than Crohn's Disease - preliminary results from the Danish IBD Biobank Project",

author = "M. Zhao and L. Larsen and A. Dige and Hvas, {C. L.} and A. Poulsen and D. Christiansen and M. Attauabi and B. Lo and M. Wewer and Ovesen, {P. D.} and Petersen, {A. M.} and F. Bendtsen and Seidelin, {J. B.} and J. Burisch",

note = "Abstract No. P405; 17th Congress of ECCO ; Conference date: 16-02-2022 Through 19-02-2022",

year = "2022",

month = jan,

doi = "10.1093/ecco-jcc/jjab232.532",

language = "English",

volume = "16",

pages = "I397--I398",

journal = "Journal of Crohn's & colitis",

issn = "1873-9946",

publisher = "Oxford University Press",

number = "Suppl. 1",

}

Zhao, M, Larsen, L, Dige, A, Hvas, CL, Poulsen, A, Christiansen, D, Attauabi, M, Lo, B, Wewer, M, Ovesen, PD, Petersen, AM, Bendtsen, F, Seidelin, JB & Burisch, J 2022, 'Primary non-response and loss-of-response to first-line biological therapies are more common in patients with Ulcerative Colitis than Crohn's Disease - preliminary results from the Danish IBD Biobank Project', Journal of Crohn's & colitis, bind 16, nr. Suppl. 1, s. I397-I398. https://doi.org/10.1093/ecco-jcc/jjab232.532

Primary non-response and loss-of-response to first-line biological therapies are more common in patients with Ulcerative Colitis than Crohn's Disease - preliminary results from the Danish IBD Biobank Project. / Zhao, M.; Larsen, L.; Dige, A. et al.
I: Journal of Crohn's & colitis, Bind 16, Nr. Suppl. 1, 01.2022, s. I397-I398.

Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › peer review

TY - ABST

T1 - Primary non-response and loss-of-response to first-line biological therapies are more common in patients with Ulcerative Colitis than Crohn's Disease - preliminary results from the Danish IBD Biobank Project

AU - Zhao, M.

AU - Larsen, L.

AU - Dige, A.

AU - Hvas, C. L.

AU - Poulsen, A.

AU - Christiansen, D.

AU - Attauabi, M.

AU - Lo, B.

AU - Wewer, M.

AU - Ovesen, P. D.

AU - Petersen, A. M.

AU - Bendtsen, F.

AU - Seidelin, J. B.

AU - Burisch, J.

N1 - Conference code: 17

PY - 2022/1

Y1 - 2022/1

U2 - 10.1093/ecco-jcc/jjab232.532

DO - 10.1093/ecco-jcc/jjab232.532

M3 - Conference abstract in journal

SN - 1873-9946

VL - 16

SP - I397-I398

JO - Journal of Crohn's & colitis

JF - Journal of Crohn's & colitis

IS - Suppl. 1

T2 - 17th Congress of ECCO

Y2 - 16 February 2022 through 19 February 2022

ER -

Zhao M, Larsen L, Dige A, Hvas CL, Poulsen A, Christiansen D et al. Primary non-response and loss-of-response to first-line biological therapies are more common in patients with Ulcerative Colitis than Crohn's Disease - preliminary results from the Danish IBD Biobank Project. Journal of Crohn's & colitis. 2022 jan.;16(Suppl. 1):I397-I398. doi: 10.1093/ecco-jcc/jjab232.532